Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Shalansky

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Addiction Science & Clinical Practice|June 6, 2025
Evaluation of a hospital-based opioid stewardship program on high-risk opioid prescribing in a Canadian setting: an interrupted time series analysisLianping Ti, Tamara Mihic, Arielle Beauchesne, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 15, 2007
N-acetylcysteine reduces urinary albumin excretion following contrast administration: evidence of biological effectAdeera Levin, Gordon E Pate, Stephen Shalansky, et al.
American Heart Journal|September 25, 2004
A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effectJohn G Webb, Gordon E Pate, Karin H Humphries, et al.
The Canadian Journal of Hospital Pharmacy|November 13, 2025
What Clinical Pharmacy Key Performance Indicator Processes of Care Were Patients Receiving across Canada in 2018? A National Patient Registry and Pooled AnalysisAmanda Carroccia, Olavo A Fernandes, Kent Toombs, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Addiction Science & Clinical Practice|June 6, 2025
Evaluation of a hospital-based opioid stewardship program on high-risk opioid prescribing in a Canadian setting: an interrupted time series analysisLianping Ti, Tamara Mihic, Arielle Beauchesne, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 15, 2007
N-acetylcysteine reduces urinary albumin excretion following contrast administration: evidence of biological effectAdeera Levin, Gordon E Pate, Stephen Shalansky, et al.
American Heart Journal|September 25, 2004
A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effectJohn G Webb, Gordon E Pate, Karin H Humphries, et al.
The Canadian Journal of Hospital Pharmacy|November 13, 2025
What Clinical Pharmacy Key Performance Indicator Processes of Care Were Patients Receiving across Canada in 2018? A National Patient Registry and Pooled AnalysisAmanda Carroccia, Olavo A Fernandes, Kent Toombs, et al.
Pageof 4